Limb Ischemia Clinical Trials

35 recruitingLast updated: July 25, 2026

There are 35 actively recruiting limb ischemia clinical trials across 16 countries. Studies span Not Applicable, Early Phase 1, Phase 3, Phase 4, Phase 1, Phase 2. Top locations include Cleveland, Ohio, United States, New York, New York, United States, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Limb Ischemia Trials at a Glance

35 actively recruiting trials for limb ischemia are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Cleveland, New York, and Dallas. Lead sponsors running limb ischemia studies include Cell Biopeutics Resources Sdn Bhd, Aplagon Oy, and Amur State Medical Academy.

Browse limb ischemia trials by phase

Treatments under study

About Limb Ischemia Clinical Trials

Looking for clinical trials for Limb Ischemia? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Limb Ischemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Limb Ischemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 35 trials

Recruiting

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Peripheral Arterial DiseaseDVTAcute Limb Ischemia+8 more
Medtronic Endovascular50 enrolled3 locationsNCT07335341
Recruiting

Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention

Peripheral Arterial DiseaseCritical Lower Limb IschemiaCritical Limb Ischemia
University Hospitals Cleveland Medical Center25 enrolled3 locationsNCT06544135
Recruiting
Early Phase 1

Nutrition in Patient With Critical Limb Ischemia

MalnutritionNutritional SupplementsCritical Limb Ischemia
Boston Medical Center30 enrolled1 locationNCT03529019
Recruiting

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

Lower Extremity Acute Limb IschemiaLE ALI
Penumbra Inc.300 enrolled38 locationsNCT06747117
Recruiting
Not Applicable

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Peripheral Artery DiseaseMajor Adverse Cardiovascular EventsMajor Adverse Limb Events+2 more
Centre Hospitalier Universitaire, Amiens134 enrolled1 locationNCT06318767
Recruiting
Not Applicable

FAZA PET/MRI in CLI Patients Pre and Post Revascularization

Critical Limb Ischemia
University Health Network, Toronto40 enrolled1 locationNCT04054609
Recruiting

Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries

Neuropathy;PeripheralLimb Ischemia
The University of Texas Health Science Center, Houston30 enrolled2 locationsNCT07387653
Recruiting
Not Applicable

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

intermittent claudicationstable coronary artery diseaseAcute Coronary Syndromes+1 more
Maria Cecilia Hospital60 enrolled1 locationNCT07588295
Recruiting
Not Applicable

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Peripheral Arterial DiseaseChronic Limb Threatening IschemiaCritical Limb Ischemia
LimFlow, Inc.100 enrolled30 locationsNCT05313165
Recruiting

Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation

Upper Limb Ischemia
Grand Hôpital de Charleroi100 enrolled2 locationsNCT06569771
Recruiting
Not Applicable

Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients

Extracorporeal Membrane Oxygenation ComplicationCompartment Syndrome of LegLimb Ischemia+1 more
Johns Hopkins University6 enrolled1 locationNCT05830721
Recruiting
Not Applicable

Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?

Artery DiseaseAtheromatousLower Limb Ischemia
Centre Hospitalier Universitaire de Nīmes54 enrolled1 locationNCT06226844
Recruiting
Phase 3

Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial

Acute Limb Ischemia
Supergene, LLC170 enrolled8 locationsNCT05372718
Recruiting

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

ClaudicationPeripheral Arterial DiseaseFemoral Arterial Calcification+1 more
Yale University50 enrolled2 locationsNCT05145478
Recruiting
Phase 4

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Buerger's DiseaseCritical Limb Ischemia
Cell Biopeutics Resources Sdn Bhd3 enrolled1 locationNCT05854615
Recruiting
Phase 4

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

Peripheral Arterial DiseaseCritical Limb Ischemia
Cell Biopeutics Resources Sdn Bhd10 enrolled1 locationNCT05854641
Recruiting

Pounce™ Thrombectomy System Retrospective Registry

Peripheral Arterial DiseaseAcute Limb Ischemia
SurModics, Inc.500 enrolled9 locationsNCT05868161
Recruiting
Phase 3

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc.250 enrolled2 locationsNCT04433572
Recruiting
Not Applicable

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

Critical Limb Ischemia (CLI)
Stentit10 enrolled1 locationNCT07006467
Recruiting

Pressure (Fractional Flow Reserve) and Flow (Vascular Flow Reserve) Measurements During Peripheral Arterial Interventions

Peripheral Arterial DiseaseCritical Limb Ischemia (CLI)
Dr. Konstantinos Katsanos100 enrolled1 locationNCT07052435